SSI Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

SSI Investment Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-351	Closed	-$203K	–	250
2025 Q4	$203K	Buy	+351	New	+$198K	0.01%	251
2025 Q2	–	Sell	-573	Closed	-$285K	–	276
2025 Q1	$285K	Hold	573	–	–	0.02%	233
2024 Q4	$298K	Hold	573	–	–	0.02%	240
2024 Q3	$354K	Hold	573	–	–	0.03%	231
2024 Q2	$317K	Hold	573	–	–	0.02%	223
2024 Q1	$333K	Sell	573 -7	-1%	-$3.93K	0.03%	221
2023 Q4	$308K	Sell	580 -1	-0.2%	-$484	0.02%	232
2023 Q3	$294K	Sell	581 -10	-2%	-$5.33K	0.02%	216
2023 Q2	$308K	Sell	591 -112	-16%	-$60.4K	0.02%	222
2023 Q1	$405K	Sell	703 -170	-19%	-$95.8K	0.03%	214
2022 Q4	$481K	Sell	873 -1	-0.1%	-$530	0.03%	230
2022 Q3	$446K	Buy	874 +1	+0.1%	+$560	0.03%	223
2022 Q2	$476K	Hold	873	–	–	0.03%	230
2022 Q1	$515K	Sell	873 -7	-0.8%	-$4.02K	0.03%	229
2021 Q4	$588K	Hold	880	–	–	0.03%	216
2021 Q3	$504K	Buy	880 +4	+0.5%	+$2.19K	0.03%	227
2021 Q2	$443K	Sell	876 -1	-0.1%	-$472	0.03%	241
2021 Q1	$398K	Hold	877	–	–	0.03%	239
2020 Q4	$407K	Hold	877	–	–	0.03%	216
2020 Q3	$387K	Sell	877 -605	-41%	-$250K	0.03%	214
2020 Q2	$536K	Sell	1,482 -14	-0.9%	-$4.69K	0.05%	187
2020 Q1	$425K	Sell	1,496 -17	-1%	-$5.36K	0.04%	193
2019 Q4	$490K	Sell	1,513 -7	-0.5%	-$2.12K	0.03%	219
2019 Q3	$443K	Hold	1,520	–	–	0.03%	225
2019 Q2	$447K	Sell	1,520 -5	-0.3%	-$1.38K	0.03%	229
2019 Q1	$416K	Sell	1,525 -8	-0.5%	-$1.99K	0.03%	222
2018 Q4	$343K	Sell	1,533 -3	-0.2%	-$704	0.03%	222
2018 Q3	$376K	Sell	1,536 -7	-0.5%	-$1.61K	0.03%	243
2018 Q2	$318K	Sell	1,543 -244	-14%	-$51.8K	0.03%	243
2018 Q1	$368K	Sell	1,787 -27	-1%	-$5.67K	0.03%	247
2017 Q4	$345K	Sell	1,814 -2	-0.1%	-$383	0.03%	255
2017 Q3	$344K	Sell	1,816 -12	-0.7%	-$2.17K	0.03%	259
2017 Q2	$320K	Sell	1,828 -22	-1%	-$3.69K	0.03%	264
2017 Q1	$282K	Sell	1,850 -2	-0.1%	-$306	0.03%	262
2016 Q4	$260K	Sell	1,852 -3	-0.2%	-$442	0.02%	261
2016 Q3	$296K	Sell	1,855 -24	-1%	-$3.7K	0.03%	243
2016 Q2	$276K	Buy	1,879 +23	+1%	+$3.4K	0.03%	238
2016 Q1	$263K	Hold	1,856	–	–	0.03%	235
2015 Q4	$265K	Hold	1,856	–	–	0.03%	239
2015 Q3	$226K	Hold	1,856	–	–	0.02%	254
2015 Q2	$239K	Sell	1,856 -482	-21%	-$62.8K	0.02%	263
2015 Q1	$314K	Buy	+2,338	New	+$301K	0.03%	246
2013 Q3	–	Sell	-9,743	Closed	-$824K	–	410
2013 Q2	$824K	Buy	+9,743	New	+$811K	0.08%	235

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SSI Investment Management's TMO Position: Q1 2026 in Review

SSI Investment Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 351 shares — an estimated $203K sold.

SSI Investment Management first reported a position in TMO in Q2 2013 and held it in 43 quarters. The position peaked at $824K in Q2 2013. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

SSI Investment Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
SSI Investment Management sold 351 Thermo Fisher Scientific shares in Q1 2026, an estimated $203K.
SSI Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 43 quarters.
SSI Investment Management's Thermo Fisher Scientific position peaked at $824K in Q2 2013.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on SSI Investment Management's 13F filing for Q1 2026, filed 14 May 2026.